132 related articles for article (PubMed ID: 25506224)
1. EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy.
Su NW; Leu YS; Lee JC; Liu CJ; Cheng CY; Lin JS; Chen YJ; Chen CK; Fang IC; Hsieh RK; Chang YF
Onco Targets Ther; 2014; 7():2197-204. PubMed ID: 25506224
[TBL] [Abstract][Full Text] [Related]
2. Association of epidermal growth factor receptor polymorphism, skin toxicity, and outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.
Klinghammer K; Knödler M; Schmittel A; Budach V; Keilholz U; Tinhofer I
Clin Cancer Res; 2010 Jan; 16(1):304-10. PubMed ID: 20028750
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.
Zhang W; Gordon M; Press OA; Rhodes K; Vallböhmer D; Yang DY; Park D; Fazzone W; Schultheis A; Sherrod AE; Iqbal S; Groshen S; Lenz HJ
Pharmacogenet Genomics; 2006 Jul; 16(7):475-83. PubMed ID: 16788380
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression.
Gao J; Ulekleiv CH; Halstensen TS
J Exp Clin Cancer Res; 2016 Sep; 35(1):151. PubMed ID: 27669890
[TBL] [Abstract][Full Text] [Related]
5. Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy.
Lai CY; Sung FC; Hsieh LL; Tang R; Chiou HY; Wu FY; Yeh CC
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S599-606. PubMed ID: 23800895
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma.
Wang W; Ma XP; Shi Z; Zhang P; Ding DL; Huang HX; Saiyin HG; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Zheng SL; Yu L; Xu J; Jiang DK
Am J Cancer Res; 2015; 5(1):396-410. PubMed ID: 25628948
[TBL] [Abstract][Full Text] [Related]
7. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M
Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of Mismatch Repair Pathway Genes Predict Clinical Outcomes in Oral Squamous Cell Carcinoma Patients Receiving Adjuvant Concurrent Chemoradiotherapy.
Senghore T; Wang WC; Chien HT; Chen YX; Young CK; Huang SF; Yeh CC
Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035658
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
10. Clinical Implication of EGF A61G Polymorphism in the Risk of Non Small Cell Lung Adenocarcinoma Patients: A Case Control Study.
Masroor M; Amit J; Javid J; Mir R; Prasant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7529-34. PubMed ID: 26625757
[TBL] [Abstract][Full Text] [Related]
11. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of pathological complete remission after preoperative irradiation in patients with locally advanced head and neck squamous cell carcinoma: re-analysis of a phase 3 clinical study.
Wang K; Yi J; Huang X; Qu Y; Luo J; Xiao J; Zhang S; Tang Y; Liu W; Xu G; Gao L; Xu Z; Liu S; Wang X
Radiat Oncol; 2019 Dec; 14(1):225. PubMed ID: 31831042
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of postoperative adjuvant radiotherapy and postoperative concurrent chemoradiotherapy for locally advanced hypopharyngeal squamous cell carcinoma].
Liu K; Zhang XX; Liu MB; Wang JL; Wu WM; Huang DL; Zhao JD; Ma L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 54(9):662-669. PubMed ID: 31550757
[No Abstract] [Full Text] [Related]
14. Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population.
Fernández-Mateos J; Seijas-Tamayo R; Mesía R; Taberna M; Pastor Borgoñón M; Pérez-Ruiz E; Adansa Klain JC; Vázquez Fernández S; Del Barco Morillo E; Lozano A; González Sarmiento R; Cruz-Hernández JJ;
Oral Oncol; 2016 Dec; 63():38-43. PubMed ID: 27938998
[TBL] [Abstract][Full Text] [Related]
15. Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.
Tinhofer I; Klinghammer K; Weichert W; Knödler M; Stenzinger A; Gauler T; Budach V; Keilholz U
Clin Cancer Res; 2011 Aug; 17(15):5197-204. PubMed ID: 21653686
[TBL] [Abstract][Full Text] [Related]
16. Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non-Small cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy.
Lim YJ; Chang JH; Kim HJ; Keam B; Kim TM; Kim DW; Paeng JC; Kang KW; Chung JK; Jeon YK; Chung DH; Wu HG
Clin Lung Cancer; 2017 May; 18(3):e169-e178. PubMed ID: 28131636
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation.
Bohanes P; Rankin CJ; Blanke CD; Winder T; Ulrich CM; Smalley SR; Rich TA; Martensen JA; Benson AB; Mayer RJ; Cripps CM; Danenberg K; Makar KW; Zhang W; Benedetti JK; Lenz HJ
Clin Cancer Res; 2015 Apr; 21(7):1583-90. PubMed ID: 25589620
[TBL] [Abstract][Full Text] [Related]
18. Identification of epidermal growth factor receptor (EGFR) exon 20 single nucleotide polymorphism in Chinese squamous cell carcinoma of head and neck (SCCHN).
Jin T; Yu CX; Jin T; Yu CX; Lei DP; Liu DY; Xu FL; Lu YT; Pan XL
Acta Otolaryngol; 2009 Nov; 129(11):1306-12. PubMed ID: 19863329
[TBL] [Abstract][Full Text] [Related]
19. Analyses of EGF A61G Gene Variation and Serum EGF Level on Gastric Cancer Susceptibility and Clinicopathological Parameters.
Cacina C; Arikan S; Düzköylü Y; Doğan MB; Okay E; Turan S; Yaylim I; Isbir T
Anticancer Res; 2015 May; 35(5):2709-13. PubMed ID: 25964549
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.
Chen YH; Lu HI; Chien CY; Lo CM; Wang YM; Chou SY; Li SH
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
